Blog Posts

Wistar scientists advanced a novel anticancer treatment that targets the endoplasmic reticulum (a word you last heard in middle school cell biology) and discovered a new function for the ARID1 protein that is frequently mutated in ovarian cancer.

In the beautiful setting of the College of Physicians of Philadelphia, Wistar friends attended this year’s Wistar Party, a celebration of Wistar science that has carried on for decades, and an opportunity for the Institute to express its gratitude to our most committed supporters.

Recently, Wistar had the great honor of bestowing its annual Women & Science’s Helen Dean King Award upon Dr. Mary-Claire King, one of the most esteemed and productive scientists of our time, in recognition of her seminal contributions to science and human health. 

Along with warmer temperatures and the beautiful blossoming across the city, spring has become synonymous with the Philadelphia Science Festival, a staple and model for similar initiatives in other cities, that continues to grow each year.

Wistar investigators receive support through the Commonwealth Universal Research Enhancement Program (CURE), which funds health research across Pennsylvania. Each year in early May, representatives from Wistar and fellow institutions who are part of the Pennsylvania Cancer Alliance engage legislators to reinforce the importance and impact of CURE funding.